Cargando…
Circulating tumour-derived DNA in metastatic soft tissue sarcoma
Following treatment 40% of soft tissue sarcoma (STS) patients suffer disease recurrence. In certain cancers circulating cell free DNA (cfDNA) and circulating tumour-derived DNA (ctDNA) characteristics correlate closely with disease burden, making them exciting potential sources of biomarkers. Despit...
Autores principales: | Eastley, Nicholas C., Ottolini, Barbara, Neumann, Rita, Luo, Jin-Li, Hastings, Robert K., Khan, Imran, Moore, David A., Esler, Claire P., Shaw, Jacqueline A., Royle, Nicola J., Ashford, Robert U. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828212/ https://www.ncbi.nlm.nih.gov/pubmed/29535826 http://dx.doi.org/10.18632/oncotarget.24278 |
Ejemplares similares
-
The Circulating Nucleic Acid Characteristics of Non-Metastatic Soft Tissue Sarcoma Patients
por: Eastley, Nicholas, et al.
Publicado: (2020) -
Telomere maintenance in soft tissue sarcomas
por: Eastley, Nicholas, et al.
Publicado: (2017) -
Detection and utility of cell-free and circulating tumour DNA in bone and soft-tissue sarcomas
por: Tsoi, Kim M., et al.
Publicado: (2021) -
Treatment Strategies for Metastatic Soft Tissue Sarcomas
por: Wiltink, Lisette M., et al.
Publicado: (2021) -
Apparent trends in the use of femoral megaprostheses: an analysis from the National Joint Registry
por: Puttock, Darren R., et al.
Publicado: (2022)